A few misconceptions tend to follow discussions of Mexican pharma. One is assuming there’s nothing to verify: in reality, prices tend to run lower than in the U.S. because Mexico’s pricing and patent-enforcement system works differently. Another common assumption gets the details backwards on cost or convenience, when in fact checking a manufacturer’s name against COFEPRIS’s public registry is a quick way to confirm legitimacy. A third misunderstanding overlooks a practical detail that matters more than people expect: packaging, trade names, and sometimes dosage forms differ from what you’d see on U.S. shelves. Clearing up these points ahead of time makes for a much more informed approach to Mexican pharma.